NCT02728219View on ClinicalTrials.gov

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

May 31, 2015

Conditions
Recurrent Hepatocellular Carcinoma
Interventions
PROCEDURE

TACE

In this study we prospectively select some early diagnosed recurrent HCC patients after radical resection with AFP conversion, then they will be treated with transcatheter arterial chemoembolization (TACE)

PROCEDURE

Hepatectomy

Repeat Hepatectomy after postoperation recurrence

Trial Locations (1)

200438

Eastern hepatobilliary surgery hospital, Shanghai

All Listed Sponsors
lead

Eastern Hepatobiliary Surgery Hospital

OTHER

NCT02728219 - Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion | Biotech Hunter | Biotech Hunter